Sang-Jun Ha

University Name

South Korea

This profile is automatically generated from trusted academic sources.

Google Scholar

ORCID

How do I reach out?

Meet Kite AI

Contact this professor

ORCID

Google Scholar

Research Interests

Immunology

90%

Cell Biology

40%

Cancer Biology

40%

Immune Response

30%

Dendritic Cell

30%

Macrophage Biology

30%

Immunomodulation

30%

Ask ApplyKite AI

Start chatting

How can you help me contact this professor?

What are this professor's research interests?

How should I write an email to this professor?

Articles11

Harnessing IL-2 for immunotherapy against cancer and chronic infection: a historical perspective and emerging trends

Article Link

Year:

2024

Reprogramming the tumor immune microenvironment using engineered dual-drug loaded Salmonella

Article Link

Year:

2024

Discovery of highly immunogenic spleen-resident FCGR3+CD103+ cDC1s differentiated by IL-33-primed ST2+ basophils

Article Link

Year:

2023

Protective Efficacy and Immunogenicity of Rv0351/Rv3628 Subunit Vaccine Formulated in Different Adjuvants Against Mycobacterium tuberculosis Infection

Article Link

Year:

2023

Chronic LCMV infection regulates the effector T cell response by inducing the generation of less immunogenic dendritic cells

Article Link

Year:

2023

Better understanding CD8+ T cells in cancer and viral infections

Article Link

Year:

2023

A novel small molecule, CU05-1189, targeting the pleckstrin homology domain of PDK1 suppresses VEGF-mediated angiogenesis and tumor growth by blocking the Akt signaling pathway

Article Link

Year:

2023

A virtual memory CD8+ T cell-originated subset causes alopecia areata through innate-like cytotoxicity

Article Link

Year:

2023

Ablation of PD-1 Reduces the Stability and Lipid Metabolism of Regulatory T Cells in the Tumor Microenvironment

Article Link

Year:

2023

Beclin1-Deficient Adipocytes Promote Tumor Progression by YAP/TAZ-dependent Adipocyte Transformation

Article Link

Year:

2023

CD161+ TRM cells counteract HPV-associated clinical benefits in oropharyngeal cancer immunotherapy

Article Link

Year:

2023

Collaborators6

Sung Jae Shin

Yonsei University College of Medicine

SOUTH KOREA

Se Jin Im

Assistant Professor

Sungkyunkwan University School of Medicine

SOUTH KOREA

Yong Taik Lim

SOUTH KOREA

Su-Hyung Park

Yonsei University College of Medicine

SOUTH KOREA

Jung-Joon Min

SOUTH KOREA

Hye Young Kim

Seoul National University College of Medicine

SOUTH KOREA

How do I reach out?

Meet Kite AI

Sang-Jun Ha

How do I reach out?

Contact this professor

Research Interests

Ask ApplyKite AI

Articles11

Harnessing IL-2 for immunotherapy against cancer and chronic infection: a historical perspective and emerging trends

Reprogramming the tumor immune microenvironment using engineered dual-drug loaded Salmonella

Discovery of highly immunogenic spleen-resident FCGR3+CD103+ cDC1s differentiated by IL-33-primed ST2+ basophils

Protective Efficacy and Immunogenicity of Rv0351/Rv3628 Subunit Vaccine Formulated in Different Adjuvants Against <i>Mycobacterium tuberculosis</i> Infection

Chronic LCMV infection regulates the effector T cell response by inducing the generation of less immunogenic dendritic cells

Better understanding CD8+ T cells in cancer and viral infections

A novel small molecule, CU05-1189, targeting the pleckstrin homology domain of PDK1 suppresses VEGF-mediated angiogenesis and tumor growth by blocking the Akt signaling pathway

A virtual memory CD8<SUP>+</SUP> T cell-originated subset causes alopecia areata through innate-like cytotoxicity

Ablation of PD-1 Reduces the Stability and Lipid Metabolism of Regulatory T Cells in the Tumor Microenvironment

Beclin1-Deficient Adipocytes Promote Tumor Progression by YAP/TAZ-dependent Adipocyte Transformation

CD161<SUP>+</SUP> T<sub>RM</sub> cells counteract HPV-associated clinical benefits in oropharyngeal cancer immunotherapy

Collaborators6

Sung Jae Shin

Se Jin Im

Yong Taik Lim

Su-Hyung Park

Jung-Joon Min

Hye Young Kim

How do I reach out?